Related references
Note: Only part of the references are listed.Analytical evaluation of the performances of a new procalcitonin immunoassay
Anne Marie Dupuy et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)
Evaluation of the Beckman Coulter Access Procalcitonin Assay: analytical and clinical performance
Hyunji Choi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)
Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials
Eva Heilmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Analytical evaluation of Reebio procalcitonin latex-enhanced immunoturbidimetric assay on the HITACHI Labospect 008AS
Shunzong Yuan et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Procalcitonin measurement by Diazyme™ immunturbidimetric and Elecsys BRAHMS™ PCT assay on a Roche COBAS modular analyzer
Andreas Jensch et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Harmonization status of procalcitonin measurements: what do comparison studies and EQA schemes tell us?
Huu-Hien Huynh et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma
Juergen Kratzsch et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients
Alberto Dolci et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Procalcitonin measurement by Diazyme (TM) immunturbidimetric and Elecsys BRAHMS (TM) PCT assay on a Roche COBAS modular analyzer
Andreas Jensch et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting
Chien-Chang Lee et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Impact of continuous renal replacement therapy (CRRT) and other extracorporeal support techniques on procalcitonin guided antibiotic therapy in critically ill patients with septic shock
Giancarlo Ceccarelli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
Philipp Schuetz et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Evaluation of procalcitonin immunoassay concordance near clinical decision points
Allison B. Chambliss et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infection
Olivia L. Neeser et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect)
Abass Eidizadeh et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials
Marc A. Meier et al.
CLINICAL INFECTIOUS DISEASES (2019)
Serum procalcitonin concentration within 2 days postoperatively accurately predicts outcome after liver resection
Yuto Aoki et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Procalcitonin for diagnosing and monitoring bacterial infections: for or against?
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysis
Juliane Hey et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Procalcitonin-guided antibiotic therapy: an expert consensus
Michele Bartoletti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials
Philipp Schuetz et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)
Reassessment of a meta-analysis of procalcitonin-guided antibiotic therapy for lower respiratory tract infections Reply
Philipp Schuetz et al.
LANCET INFECTIOUS DISEASES (2018)
Antimicrobial resistance: a threat to global health
Youngmee Jee et al.
LANCET INFECTIOUS DISEASES (2018)
Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials
Yannick Wirz et al.
CRITICAL CARE (2018)
Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis
Jonas Odermatt et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis
Philipp Schuetz et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Management of Respiratory Infections with Use of Procalcitonin: Moving toward More Personalized Antibiotic Treatment Decisions
Yannick Wirz et al.
ACS INFECTIOUS DISEASES (2017)
Are admission procalcitonin levels universal mortality predictors across different medical emergency patient populations? Results from the multi-national, prospective, observational TRIAGE study
Ramon Sager et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
Philipp Schuetz et al.
CRITICAL CARE MEDICINE (2017)
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective
Ivana Stojanovic et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Procalcitonin-guided diagnosis and antibiotic stewardship revisited
Ramon Sager et al.
BMC MEDICINE (2017)
Comparison between BRAHMS PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods - a prospective multinational trial
Alexander Kutz et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Procalcitonin: A new biomarker for the cardiologist
Philipp Schuetz et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
Evelien de Jong et al.
LANCET INFECTIOUS DISEASES (2016)
Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial
Nga T. T. Do et al.
LANCET GLOBAL HEALTH (2016)
Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia
Andriy Zhydkov et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective
Philipp Schuetz et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Community-Acquired Pneumonia Requiring Hospitalization among US Adults
S. Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Biomarker-guided personalised emergency medicine for all - hope for another hype?
Philipp Schuetz et al.
SWISS MEDICAL WEEKLY (2015)
Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study
Philipp Schuetz et al.
CRITICAL CARE (2015)
Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: Results from the randomized ProHOSP trial
Philipp Schuetz et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Community-Acquired Pneumonia
Daniel M. Musher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Promising New Assays and Technologies for the Diagnosis and Management of Infectious Diseases
S. F. Mitsuma et al.
CLINICAL INFECTIOUS DISEASES (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R. P. Dellinger et al.
INTENSIVE CARE MEDICINE (2013)
Early Serum Procalcitonin Level after Primary Total Hip Replacement
Samy Bouaicha et al.
MEDIATORS OF INFLAMMATION (2013)
Long-term stability of procalcitonin in frozen samples and comparison of Kryptor® and VIDAS® automated immunoassays
Philipp Schuetz et al.
CLINICAL BIOCHEMISTRY (2010)
The Value of Serum Procalcitonin Level for Differentiation of Infectious from Noninfectious Causes of Fever After Orthopedic Surgery
Sabina Hunziker et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2010)
Procalcitonin in intensive care units: the PRORATA trial
Gijs W. Landman et al.
LANCET (2010)
Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections The ProHOSP Randomized Controlled Trial
Philipp Schuetz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Share Paper
